Galantamine-induced improvements in cognitive function are not related to alterations in α4β2 nicotinic receptors in early Alzheimer’s disease as measured in vivo by 2-[18F]Fluoro-A-85380 PET

Author: Ellis J.   Nathan P.   Villemagne V.   Mulligan R.   Saunder T.   Young K.   Smith C.   Welch J.   Woodward M.   Wesnes K.   Savage G.   Rowe C.  

Publisher: Springer Publishing Company

ISSN: 0033-3158

Source: Psychopharmacology, Vol.202, Iss.1-3, 2009-01, pp. : 79-91

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content